Harvard Bioscience to Attend Canaccord Genuity MedTech, Diagnostics, and Digital Health and Services Forum

PUBT · 1d ago
Harvard Bioscience to Attend Canaccord Genuity MedTech, Diagnostics, and Digital Health and Services Forum
  • Harvard Bioscience will attend Canaccord Genuity's MedTech, Diagnostics, and Digital Health and Services Forum on Nov. 11, 2026.
  • CEO John Duke and CFO Mark Frost will participate in one-on-one meetings.
  • Duke will present on the “Emerging Tools for Research and Biopharma Use Cases” panel at 9:30 a.m. ET.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harvard Bioscience Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611040730PRIMZONEFULLFEED9869671) on November 04, 2026, and is solely responsible for the information contained therein.